Jacobs Levy Equity Management’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.18M | Buy |
368,447
+351,960
| +2,135% | +$7.81M | 0.03% | 339 |
|
|
2025
Q1 | $306K | Sell |
16,487
-68,894
| -81% | -$1.28M | ﹤0.01% | 977 |
|
|
2024
Q4 | $1.13M | Buy |
85,381
+39,307
| +85% | +$520K | ﹤0.01% | 695 |
|
|
2024
Q3 | $1.54M | Sell |
46,074
-1,129
| -2% | -$37.8K | 0.01% | 651 |
|
|
2024
Q2 | $1.18M | Sell |
47,203
-2,186
| -4% | -$54.8K | ﹤0.01% | 694 |
|
|
2024
Q1 | $1.11M | Buy |
49,389
+13,764
| +39% | +$310K | 0.01% | 698 |
|
|
2023
Q4 | $763K | Sell |
35,625
-171,160
| -83% | -$3.67M | ﹤0.01% | 769 |
|
|
2023
Q3 | $3.71M | Buy |
206,785
+8,064
| +4% | +$145K | 0.02% | 434 |
|
|
2023
Q2 | $4.04M | Buy |
198,721
+39,214
| +25% | +$798K | 0.02% | 442 |
|
|
2023
Q1 | $3.47M | Buy |
+159,507
| New | +$3.47M | 0.02% | 471 |
|
|
2022
Q3 | – | Sell |
-15,196
| Closed | -$308K | – | 990 |
|
|
2022
Q2 | $308K | Sell |
15,196
-96,211
| -86% | -$1.95M | ﹤0.01% | 921 |
|
|
2022
Q1 | $2.76M | Buy |
111,407
+22,090
| +25% | +$546K | 0.02% | 556 |
|
|
2021
Q4 | $3.1M | Buy |
89,317
+889
| +1% | +$30.9K | 0.02% | 523 |
|
|
2021
Q3 | $2.4M | Sell |
88,428
-738
| -0.8% | -$20K | 0.02% | 576 |
|
|
2021
Q2 | $2.31M | Sell |
89,166
-5,039
| -5% | -$131K | 0.02% | 567 |
|
|
2021
Q1 | $2.03M | Buy |
94,205
+22,827
| +32% | +$492K | 0.02% | 595 |
|
|
2020
Q4 | $1.54M | Buy |
71,378
+527
| +0.7% | +$11.3K | 0.01% | 628 |
|
|
2020
Q3 | $1.05M | Buy |
70,851
+7,260
| +11% | +$107K | 0.01% | 655 |
|
|
2020
Q2 | $1.42M | Buy |
63,591
+29,006
| +84% | +$648K | 0.02% | 596 |
|
|
2020
Q1 | $489K | Buy |
+34,585
| New | +$489K | 0.01% | 757 |
|